From: Natalizumab in the pediatric MS population: results of the Italian registry
Mean (SD) | |
---|---|
Age at MS onset (years) | 12.9 (2.7) |
Pre-NA disease duration (months) | 25.6 (23.3) |
Age at NA initiation (years) | 14.7 (2.4) |
Weight (Kg) | 62.0 (13.3) |
Height (cm) | 163.5 (12.3) |
Number of relapses prior NA initiation | 4.0 (2.2) |
Number of relapses in the year prior NA initiation | 2.3 (1.3) |
Number of Gd + MRI lesions prior NA initiation | 3.3 (4.4) |
EDSS at NA initiation | 2.6 (1.3) |